Wednesday, June 29, 2016 12:24:14 AM
Given the share performance, I will not be surprised if several of the votes fail again. Nor will I be particularly upset if that is the result. In my personal opinion, the matters in issues 2,3, & 4 were too expansive in the powers granted.
The proposed equity incentive plan and the bylaw amendment both appear to essentially grant the board power to change anything at anytime. What's the point of having a plan or rules, if you can change them at will? What's the point in voting then?
And while I have no real problem with letting the board vote to adjust its size within reason, I feel there should be some limitation. Did we really need to authorize them to reduce the board to 1 member?
In any event, I am satisfied with the company's overall performance, and I am glad my standing buy order finally triggered yesterday at $2.21. I wasn't watching closely, but it looked like substantial support came in to hold at $2.20.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM